Get the Stockscreener App
5.57
3.13%
-0.18
After Hours:
5.68
0.11
+1.97%
Alvotech stock is traded at $5.57, with a volume of 425.37K.
It is down -3.13% in the last 24 hours and down -0.54% over the past month.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
See More
Previous Close:
$5.75
Open:
$5.75
24h Volume:
425.37K
Relative Volume:
0.79
Market Cap:
$1.74B
Revenue:
$391.87M
Net Income/Loss:
$-441.45M
P/E Ratio:
-3.0108
EPS:
-1.85
Net Cash Flow:
$-301.21M
1W Performance:
+1.83%
1M Performance:
-0.54%
6M Performance:
-43.39%
1Y Performance:
-52.23%
1-Day Range:
$5.40
$5.78
1-Week Range:
$5.23
$5.85
52-Week Range:
$4.32
$13.70
Alvotech Stock (ALVO) Company Profile
Compare ALVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
5.57 | 1.79B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Underweight |
| Nov-04-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-14-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-14-25 | Initiated | UBS | Buy |
| Jan-29-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Upgrade | Citigroup | Sell → Neutral |
| Sep-21-23 | Initiated | Barclays | Equal Weight |
| Sep-07-22 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-06-22 | Downgrade | Citigroup | Buy → Sell |
| Jul-26-22 | Initiated | Citigroup | Buy |
View All
Alvotech Stock (ALVO) Latest News
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
How Investors Are Reacting To Alvotech (ALVO) EU Approval Of AVT03 Denosumab Biosimilar - Sahm
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Defic - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AlvotechALVO - PR Newswire
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman - PR Newswire
Barclays Initiates Coverage of Alvotech (ALVO) with Underweight Recommendation - Nasdaq
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bakersfield.com
ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire
Alvotech (NASDAQ:ALVO) Shares Gap DownHere's Why - MarketBeat
Alvotech (ALVO) Receives Underweight Rating from Barclays | ALVO Stock News - GuruFocus
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - The Malaysian Reserve
Alvotech initiated with an Underweight at Barclays - TipRanks
Barclays Downgrades Alvotech(ALVO.US) to Sell Rating, Cuts Target Price to $5 - 富途牛牛
Certain Ordinary Shares of Alvotech are subject to a Lock-Up Agreement Ending on 8-DEC-2025. - marketscreener.com
Certain Swedish Depository Receipts of Alvotech are subject to a Lock-Up Agreement Ending on 8-DEC-2025. - marketscreener.com
What analysts say about Alvotech Z45 stockVolume Profile Analysis & Free Discover Dynamic Stocks - earlytimes.in
With Alvotech Stock Surging, Have You Considered The Downside? - Trefis
Alvotech Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Retail Surge: What technical signals suggest for BRT Apartments Corp stockTrade Risk Report & High Return Stock Watch Alerts - BỘ NỘI VỤ
Alvotech (NASDAQ:ALVO) Stock Price Up 6.3%Here's What Happened - MarketBeat
Alvotech (NasdaqGM:ALVO): Assessing Valuation After European Approval of Denosumab Biosimilar AVT03 - simplywall.st
How Alvotech Z45 stock correlates with oil marketsQuarterly Investment Review & Daily Profit Maximizing Tips - BỘ NỘI VỤ
Alvotech (ICSE:ALVO) Price Target Decreased by 17.29% to 1,165.86 - Nasdaq
ROSEN, LEADING INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - marketscreener.com
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Alvotech (ALVO) - ACCESS Newswire
Would You Still Hold Alvotech Stock If It Fell 30%? - Trefis
Oaktree Capital Management LP Trims Position in Alvotech $ALVO - MarketBeat
Does Alvotech (Z45) stock trade below intrinsic valueQuarterly Portfolio Review & Entry Point Confirmation Signals - Newser
Will Alvotech (Z45) stock hit analyst forecasts2025 EndofYear Setup & Safe Entry Zone Tips - Newser
Alvotech Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Why Alvotech (Z45) stock remains stableWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Alvotech (ALVO): A Bull Case Theory - Finviz
Will Alvotech (Z45) stock beat Nasdaq index returnsJuly 2025 Price Swings & Capital Efficient Trade Techniques - Newser
Is Alvotech Equity Warrant stock a safe haven assetJuly 2025 Earnings & Reliable Volume Spike Alerts - Newser
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO - The AI Journal
ALVO ALERT: Levi & Korsinsky Investigates Alvotech for Possible Securities Fraud Violations - ACCESS Newswire
What momentum indicators show for Alvotech stockWeekly Trade Analysis & Verified Momentum Stock Alerts - Newser
Alvotech (NASDAQ:ALVO) Reaches New 12-Month LowWhat's Next? - MarketBeat
Morgan Stanley Maintains Alvotech(ALVO.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
What technical patterns form on Alvotech (Z45) stock chartsPortfolio Return Report & Smart Money Movement Alerts - Newser
Will Alvotech (Z45) stock rise with strong economyJuly 2025 Levels & Technical Entry and Exit Tips - Newser
Alvotech stock hits 52-week low at 4.69 USD By Investing.com - Investing.com Nigeria
Alvotech stock hits 52-week low at 4.69 USD - Investing.com
Alvotech, Advanz Pharma secure European approval for Gobivaz, Simponi biosimilar - MSN
How Alvotech (Z45) stock trades under stagflation2025 Retail Activity & Long-Term Safe Investment Plans - Newser
Why Alvotech (Z45) stock appeals to dividend investors2025 Price Momentum & Short-Term Swing Trade Alerts - Newser
European Commission Approves Denosumab Biosimilars for Alvotech, STADA, Dr. Reddy’s & Teva - Pearce IP
The SPC "Waiver Regulation" means what it says: Regeneron v Alvotech - Mishcon de Reya LLP
Bronstein, Gewirtz & Grossman, LLC Encourages Alvotech (ALVO) Sto - The National Law Review
What analysts say about Alvotech Equity Warrant stockMarket Correction Analysis & Affordable Portfolio Strategies - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Alvotech (ALVO) Sha - The National Law Review
Alvotech Stock (ALVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.48%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):